rosiglitazone has been researched along with Antibody Deficiency Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnal, JF; Authier, H; Auwerx, J; Balard, P; Bernad, J; Coste, A; Douin-Echinard, V; Filipe, C; Galès, A; Lagane, C; Lepert, JC; Linas, MD; Pipy, B | 1 |
1 other study(ies) available for rosiglitazone and Antibody Deficiency Syndrome
Article | Year |
---|---|
IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation.
Topics: Animals; Candida albicans; Candidiasis; Cecum; Cell Movement; DNA-Binding Proteins; Female; Gastrointestinal Diseases; Immunologic Deficiency Syndromes; Interleukin-13; Lectins, C-Type; Ligands; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Knockout; PPAR gamma; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones | 2008 |